These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36556226)

  • 1. IGFBP2 Drives Regulatory T Cell Differentiation through STAT3/IDO Signaling Pathway in Pancreatic Cancer.
    Sun L; Zhang Y; Yang T; Chen J; Zhang X; Liang X
    J Pers Med; 2022 Dec; 12(12):. PubMed ID: 36556226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGFBP2 promotes tumor progression by inducing alternative polarization of macrophages in pancreatic ductal adenocarcinoma through the STAT3 pathway.
    Sun L; Zhang X; Song Q; Liu L; Forbes E; Tian W; Zhang Z; Kang Y; Wang H; Fleming JB; Pasche BC; Zhang W
    Cancer Lett; 2021 Mar; 500():132-146. PubMed ID: 33309859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Paradoxical Role for Regulatory T Cells in the Tumor Microenvironment of Pancreatic Cancer.
    Brouwer T; Ijsselsteijn M; Oosting J; Ruano D; van der Ploeg M; Dijk F; Bonsing B; Fariña A; Morreau H; Vahrmeijer A; Miranda N
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum insulin-like growth factor binding protein 2 levels as biomarker for pancreatic ductal adenocarcinoma-associated malnutrition and muscle wasting.
    Dong J; Yu J; Li Z; Gao S; Wang H; Yang S; Wu L; Lan C; Zhao T; Gao C; Liu Z; Wang X; Hao J
    J Cachexia Sarcopenia Muscle; 2021 Jun; 12(3):704-716. PubMed ID: 33763996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IGFBP2 Activates the NF-κB Pathway to Drive Epithelial-Mesenchymal Transition and Invasive Character in Pancreatic Ductal Adenocarcinoma.
    Gao S; Sun Y; Zhang X; Hu L; Liu Y; Chua CY; Phillips LM; Ren H; Fleming JB; Wang H; Chiao PJ; Hao J; Zhang W
    Cancer Res; 2016 Nov; 76(22):6543-6554. PubMed ID: 27659045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-506 Promotes Antitumor Immune Response in Pancreatic Cancer by Reprogramming Tumor-Associated Macrophages toward an M1 Phenotype.
    Yang T; Han Y; Chen J; Liang X; Sun L
    Biomedicines; 2023 Oct; 11(11):. PubMed ID: 38001876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and diagnostic value of circulating IGFBP2 in pancreatic cancer.
    Xu J; Song Y; Zhou B; Yuan S; Gao S
    Open Med (Wars); 2024; 19(1):20230893. PubMed ID: 39221034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Treg-Expressed STAT3 Enhances NK-Mediated Surveillance of Metastasis and Improves Therapeutic Response in Pancreatic Adenocarcinoma.
    Piper M; Van Court B; Mueller A; Watanabe S; Bickett T; Bhatia S; Darragh LB; Mayeda M; Nguyen D; Gadwa J; Knitz M; Corbo S; Morgan R; Lee JJ; Dent A; Goodman K; Messersmith W; Schulick R; Del Chiaro M; Zhu Y; Kedl RM; Lenz L; Karam SD
    Clin Cancer Res; 2022 Mar; 28(5):1013-1026. PubMed ID: 34862244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-cell RNA-seq reveals dynamic change in tumor microenvironment during pancreatic ductal adenocarcinoma malignant progression.
    Chen K; Wang Q; Li M; Guo H; Liu W; Wang F; Tian X; Yang Y
    EBioMedicine; 2021 Apr; 66():103315. PubMed ID: 33819739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indoleamine 2,3-Dioxygenase Activity-Induced Acceleration of Tumor Growth, and Protein Kinases-Related Novel Therapeutics Regimens.
    Engin AB; Engin A
    Adv Exp Med Biol; 2021; 1275():339-356. PubMed ID: 33539022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
    Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
    Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGFBP2 potentiates nuclear EGFR-STAT3 signaling.
    Chua CY; Liu Y; Granberg KJ; Hu L; Haapasalo H; Annala MJ; Cogdell DE; Verploegen M; Moore LM; Fuller GN; Nykter M; Cavenee WK; Zhang W
    Oncogene; 2016 Feb; 35(6):738-47. PubMed ID: 25893308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal Transducer and Activator of Transcription 3, Mediated Remodeling of the Tumor Microenvironment Results in Enhanced Tumor Drug Delivery in a Mouse Model of Pancreatic Cancer.
    Nagathihalli NS; Castellanos JA; Shi C; Beesetty Y; Reyzer ML; Caprioli R; Chen X; Walsh AJ; Skala MC; Moses HL; Merchant NB
    Gastroenterology; 2015 Dec; 149(7):1932-1943.e9. PubMed ID: 26255562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-infiltrating Treg, MDSC, and IDO expression associated with outcomes of neoadjuvant chemotherapy of breast cancer.
    Li F; Zhao Y; Wei L; Li S; Liu J
    Cancer Biol Ther; 2018 Aug; 19(8):695-705. PubMed ID: 29621426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry.
    Brouwer TP; de Vries NL; Abdelaal T; Krog RT; Li Z; Ruano D; Fariña A; Lelieveldt BPF; Morreau H; Bonsing BA; Vahrmeijer AL; Koning F; de Miranda NFCC
    J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma.
    Maeda S; Kuboki S; Nojima H; Shimizu H; Yoshitomi H; Furukawa K; Miyazaki M; Ohtsuka M
    Cytokine; 2017 Jul; 95():12-21. PubMed ID: 28214673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreatic stellate cell secreted IL-6 stimulates STAT3 dependent invasiveness of pancreatic intraepithelial neoplasia and cancer cells.
    Nagathihalli NS; Castellanos JA; VanSaun MN; Dai X; Ambrose M; Guo Q; Xiong Y; Merchant NB
    Oncotarget; 2016 Oct; 7(40):65982-65992. PubMed ID: 27602757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-neuroglia interaction promotes pancreatic cancer metastasis.
    Su D; Guo X; Huang L; Ye H; Li Z; Lin L; Chen R; Zhou Q
    Theranostics; 2020; 10(11):5029-5047. PubMed ID: 32308766
    [No Abstract]   [Full Text] [Related]  

  • 19. L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression.
    Grage-Griebenow E; Jerg E; Gorys A; Wicklein D; Wesch D; Freitag-Wolf S; Goebel L; Vogel I; Becker T; Ebsen M; Röcken C; Altevogt P; Schumacher U; Schäfer H; Sebens S
    Mol Oncol; 2014 Jul; 8(5):982-97. PubMed ID: 24746181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose gemcitabine depletes regulatory T cells and improves survival in the orthotopic Panc02 model of pancreatic cancer.
    Shevchenko I; Karakhanova S; Soltek S; Link J; Bayry J; Werner J; Umansky V; Bazhin AV
    Int J Cancer; 2013 Jul; 133(1):98-107. PubMed ID: 23233419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.